Cisplatin
- Product NDC
- 70860-206
- 11-digit product format
- 708600206
- Labeler code
- 70860
- Product ID
- 70860-206_01c7a680-ee0d-42da-85e8-8d56c6fe7006
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cisplatin
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA207323
- Marketing category
- ANDA
- Marketing start
- 2017-06-12
- Marketing end
- 0000-00-00
- Substance
- CISPLATIN
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Platinum-based Drug [EPC],Platinum-containing Compounds [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-206-50 | 70860020650 | 1 VIAL in 1 CARTON (70860-206-50) > 50 mL in 1 VIAL | 1 vial | 2017-06-12 | 0000-00-00 | No | No | Current |
| 70860-206-51 | 70860020651 | 1 VIAL in 1 CARTON (70860-206-51) > 100 mL in 1 VIAL | 1 vial | 2017-10-16 | 0000-00-00 | No | No | Current |